1McCabe AJ, Wilcox DT, Holm BA, et al: Surfactant-a review for pediatric surgeons. J Pediatr Surg, 2000, 35 (12):1687-700.
2Ramet M, Haataja R, Marttila R, et al. Association between the surfactant protein A(SP-A) gene locus and respiratory distress sydrome in the Finnish population. Am J Hum Genet, 2000, 66(5): 1569-79.
3Cho K, Matsuda T, Okajima S, et al. Prediction of respiratory distress syndrome by the level of pulmonary surfactant protein A in cord blood sera. Biol Neonate, 2000, 77(2):83- 7.
4Cole FS, Hamvas A, Rubinatein P, et al. Population-based estimates of surfactant protein B deficiency. Pediatrics, 2000,105 (3Pt1): 538-41.
5Soll RF. Prophylactic synthetic surfactant for preventing morbidity and mortality in preterm infants. Cochrane Datadase Syst Rev, 2000; (2): CD001079.
6Soll RF. Prophylactic natural surfactant extract for preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev, 2000;(2):CD000511.
7Soll RF. Natrual surfactant extract versus sythetic surfactant for neonatal respiratory distress syndrome. Cochrane Database Syst Rev, 2000; (2): CD000144.
8Soll RF. Multiple versus single dose natural surfactant extract for severe neonatal respiratory distress sydrome. Cochrane Database Syst Rev, 2000; (2) :CD000141.
9Yost CC, Soll RF. Early versus delayed selective surfactant treatment for neonatal respiratory distress sydrome. Cochrane Database Syst Rev, 2000: (2) :CD001456.
10Sinkin RA, Kramer BM, Merzbach JL, et al. School-age follow- up of prophylactic versus surfactant trial: pulmonary, neurodevelopmental, and educational outcomes. Pediatrics,1998, 101(5):E11.
